ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 121 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $4,570,000 | -41.9% | 200,000 | -33.3% | 0.91% | -60.1% |
Q4 2017 | $7,860,000 | -63.5% | 300,000 | -68.8% | 2.28% | -59.4% |
Q3 2017 | $21,552,000 | -34.3% | 960,000 | -20.0% | 5.62% | -21.8% |
Q2 2017 | $32,820,000 | +99.4% | 1,200,000 | +76.5% | 7.19% | +138.6% |
Q1 2017 | $16,456,000 | +98.3% | 680,000 | +70.0% | 3.01% | +66.1% |
Q4 2016 | $8,300,000 | -23.9% | 400,000 | 0.0% | 1.81% | +51.8% |
Q3 2016 | $10,904,000 | +8.2% | 400,000 | -42.9% | 1.20% | +10.5% |
Q2 2016 | $10,073,000 | -29.9% | 700,000 | -30.0% | 1.08% | +9.1% |
Q1 2016 | $14,370,000 | -55.4% | 1,000,000 | -33.3% | 0.99% | -48.4% |
Q4 2015 | $32,235,000 | +232.0% | 1,500,000 | +150.0% | 1.92% | +261.3% |
Q3 2015 | $9,708,000 | -37.3% | 600,000 | 0.0% | 0.53% | -43.6% |
Q2 2015 | $15,486,000 | +14.7% | 600,000 | 0.0% | 0.94% | +16.0% |
Q1 2015 | $13,500,000 | +61.7% | 600,000 | +37.9% | 0.81% | +29.5% |
Q4 2014 | $8,348,000 | +55.5% | 435,000 | +74.0% | 0.63% | +44.4% |
Q3 2014 | $5,370,000 | – | 250,000 | – | 0.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 4,387,590 | $46,772,000 | 15.62% |
ORACLE INVESTMENT MANAGEMENT INC | 4,091,749 | $43,618,000 | 5.75% |
GRIFFIN ASSET MANAGEMENT, INC. | 1,439,613 | $15,346,000 | 2.36% |
Selkirk Management LLC | 348,805 | $3,718,000 | 1.18% |
Chicago Capital, LLC | 1,966,891 | $20,967,000 | 1.08% |
Trellus Management Company, LLC | 46,834 | $499,000 | 0.51% |
Cannell & Co. | 1,118,439 | $11,923,000 | 0.44% |
OAKTOP CAPITAL MANAGEMENT II, L.P. | 155,000 | $1,652,000 | 0.36% |
Belpointe Asset Management LLC | 419,406 | $3,982,000 | 0.27% |
TCI Wealth Advisors, Inc. | 55,586 | $593,000 | 0.23% |